Home › Funds › Champlain Investment Partners, LLC › STE
Champlain Investment Partners, LLC position in STE
STERIS PLC · Health Care
Champlain Investment Partners, LLC reported holding 165,810 shares of STE (STERIS PLC) in its Q3 2026 13F filing — a position valued at US$34.8M, representing 1.20% of its reported portfolio and ranking #15 among its reported holdings. Champlain Investment Partners, LLC has disclosed STE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Champlain Investment Partners, LLC's STE position evolved
Champlain Investment Partners, LLC first disclosed a stake in STE in Q3 2023 at 1,078,477 shares (US$236.6M). Across 13 filings, Champlain Investment Partners, LLC increased the stake 3 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 165,810 shares valued at US$34.8M — an increase of 56,580 shares quarter over quarter.. Notable position changes include a 48% trim in Q3 2024 (shares fell 15% over the following quarter), a 62% trim in Q2 2026 (shares were roughly flat over the following quarter), a 52% increase in Q3 2026 (shares rose 22% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.08M | $236.64M | New |
| Q4 2023 | 1.06M | $233.61M | Reduce |
| Q1 2024 | 1.04M | $232.79M | Reduce |
| Q2 2024 | 1.02M | $223.14M | Reduce |
| Q3 2024 | 523.62K | $127.00M | Reduce |
| Q4 2024 | 547.45K | $112.53M | Add |
| Q1 2025 | 403.20K | $91.39M | Reduce |
| Q2 2025 | 416.84K | $100.13M | Add |
| Q3 2025 | 389.19K | $96.30M | Reduce |
| Q4 2025 | 324.60K | $82.29M | Reduce |
| Q1 2026 | 284.27K | $62.86M | Reduce |
| Q2 2026 | 109.23K | $23.00M | Reduce |
| Q3 2026 | 165.81K | $34.82M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About STE and 13F data
STE (STERIS PLC) is a Health Care company. 26 other funds we track also report a position in STE — the largest reported positions include Orbis Allan Gray Ltd (US$563.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$480.2M), Select Equity Group, L.P. (US$399.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STE
- Orbis Allan Gray Ltd 2.68M sh · $563.85M · Q2 2026
- GENERATION INVESTMENT MANAGEMENT LLP 2.28M sh · $480.25M · Q2 2026
- Select Equity Group, L.P. 1.89M sh · $398.96M · Q2 2026
More on Champlain Investment Partners, LLC
FAQ
How long has Champlain Investment Partners, LLC held STE?
Champlain Investment Partners, LLC has disclosed STE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Champlain Investment Partners, LLC's current position in STE?
As of Q3 2026, Champlain Investment Partners, LLC holds 165.81K shares of STE (STERIS PLC), valued at $34.82M, representing 1.20% of its reported portfolio and ranking #15.
Has Champlain Investment Partners, LLC been buying or selling STE?
In the latest 13F filing (Q3 2026), Champlain Investment Partners, LLC increased its position in STE.
Which other funds hold STE?
Other major institutional holders of STE include Orbis Allan Gray Ltd, GENERATION INVESTMENT MANAGEMENT LLP, Select Equity Group, L.P., among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.